Plus therapeutics to present virtually at the 2022 hc wainwright global investment conference

Austin, texas, may 18, 2022 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv), a clinical-stage pharmaceutical company developing innovative, targeted radiotherapeutics for rare and difficult-to-treat cancers, announced today that marc hedrick, m.d., president and chief executive officer, will present virtually at the 2022 h.c. wainwright global investment conference being held may 23-26, 2022.
PSTV Ratings Summary
PSTV Quant Ranking